Del Vecchyo CC, Jiménez MLG, Torres BI, Gordillo HJ

Language: Spanish
References: 25
Page: 33-36
PDF size: 142.53 Kb.

ABSTRACT

A statistical report is presented of patients with adjuvant disease from the last three years in the Plastic and Reconstructive Surgery Department of the Hospital General de México. We carried out research based on files from the «Dr. Fernando Ortiz Monasterio» Plastic Surgery Unit at the Hospital General de México, integrated by 177 patients: 128 (72.4%) females and 49 (27.6) males, between 17 and 73 years old with a mean of 39.5 years during the period from 2008 to 2011. The infiltrated region was distributed as follows: 95 patients (53.6%) in the buttocks, 52 (29.39%) in breasts, 16 (9.03%) in the legs, 9 (5.09%) in the face and 5 (2.89%) in the hip. The average time to show symptoms after the injection was 8.8 years, ranging between one and 30 years. 21 patients (11.86%) had an ulceration at the time of consultation, 42 (23.72%) underwent a surgical procedure among which lumbar perforator flaps for buttocks, reconstruction by mastectomy to remove infiltrated tissue covered with latissimus dorsi or TRAM flap over implants or not, and 135 (76.28%) only with medical handling. It is important to diagnose patients from their first contact and thereby, provide prompt medical treatment before complications given the natural history of the disease. Patients should receive close monitoring, explaining to them step by step the process of the illness. They should receive interdisciplinary handling. They must have a prognosis and be assessed whether they can be candidates for immediate reconstruction or should continue with medical treatment. Reconstruction in adjuvant disease patients with the use of autologous tissue shows fewer complications and better cosmetic results.

REFERENCES

1. Rees T, Platt J, Ballantine D. An investigation of cutaneous response to dimethylpolysiloxane (silicone liquid) in animals and humans, a preliminary report. Plast Reconstr Surg 1965; 35(2): 131-139.

2. Ortiz Monasterio F, Trigos I. Management of patients with complications from injections of foreign materials into the breast. Plast Reconstr Surg 1972; 50(1): 42-47.

3. Weisman M, Vecchione T, Albert D, Moore L, Mueller M. Connective tissue disease following breast augmentation: a preliminary test of human adjuvant disease hypothesis. Plast Reconstr Surg 1988; 82(4): 626-630.

4. Hage J, Kanhai CJ, Oen AL et al. The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transexuals. Plast Reconstr Surg 2001; 107(3): 734-741.

5. Cohen J, Keoleian C, Krull E. Penile paraffinoma: Self-injection with mineral oil. J Am Acad Dermatol 2001; 45: 222-224.

6. Santos P, Chaveiro A, Nunes G, Fonseca J, Cardoso J. Penile. Paraffinoma. JAEDV 2003; 17: 583-584.

7. Ellenbogen, R. Injectable Fluid Silicone Therapy. JAMA 1975; 234(3): 308-309.

8. Enríquez J, Alcalá D, González KI et al. Lipogranuloma esclerosante por modelantes. Rev Cent Dermatol Pascua 2007; 16(1): 19-23.

9. Behar T, Anderson EE, Barwick WJ. Sclerosing Lipogranulomatosis: a case report of scrotal injection of automobile transmission fluid and literature review of subcutaneous injection of oils. Plast Reconstr Surg 1993; 91(2): 352-361.

10. Cabral A. Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Rev Invest Clin 1994; 46(4): 257-266.

11. Arenas R, Milla L, Castillo JM. Paniculitis granulomatosa por guayacol en aceite de sésamo. Estudio de 3 casos. Dermatol Rev Mex 1988; 32: 148-154.

12. Darsow U, Bruckbauer H, Worret W, Hofman H, Ring H. Subcutaneous oleomas induced by self-injection of sesame seed oil for muscle augmentation. J Am Acad Dermatol 2000; 42: 292-294.

13. Feldman R, Harms M, Chavaz P, Salomon D, Saurat H. Orbital and palpebral paraffinoma. J Am Acad Dermatol 1992; 26: 833-835.

14. Klein J, Cole G, Barr R, Bartlow G, Fulwider C. Paraffinomas of the Scalp. Arch Dermatol 1985; 121: 382-385.

15. Rak E, Seog K, Young K, Yong L, Hyun C. Paraffinoma of the labia. Plast Reconstr Surg 2004; 113: 1885-1887.

16. Ho WS, Chan CW, Law BK. Management of paraffinoma of the breast: 10 years’ experience. Br J Plast 2001; 54: 232-234.

17. Gutiérrez E, Durán H, Duffy BE et al. Mastectomía y reconstrucción inmediata bilateral en lipogranuloma esclerosante mamario causado por inyección de modelantes. Reporte de un caso. Cir Plast 2003; 13:123-127.

18. Haddad JL, Nieto A, Saade A et al. Reconstrucción mamaria con colgajo de TRAM bilateral en pacientes mastectomizadas por mastopatía por modelantes. Ann Med 2006; 51(1): 24-28.

19. Gutiérrez E, Durán H, Duffy B, Fernández G, Papadópulos A. Mastectomía y reconstrucción inmediata bilateral en lipogranuloma esclerosante mamario causado por inyección de modelantes. Reporte de un caso. Cir Plast 2003; 13(3): 123-127.

20. Matón G, Anseeuw A, De Keyser F. The history of injectable biomaterials and the biology of collagen. Aesth Plast Surg 1985; 9: 133-140.

21. Rollins CE, Reiber G, Guinee DG Jr, Lie JT. Disseminated lipogranulomas and sudden death from self-administered mineral oil injection. Am J Forensic Med Pathol 1997; 18:100-103.

22. Duffy D. The silicone conundrum: a battle of anecdotes. Dermatol Surg 2002; 28: 590-595.

23. Labastida O, Jaimes E, Saúl A. Enfermedad humana por adyuvantes. Reporte de un caso y revisión de la literatura. Dermatol Rev Mex 1992; 36: 298-301.

24. Romano E, Giavarini A, Monti J. Granuloma por siliconas. Rev Arg Dermatol 1991; 72: 209-211.

25. Benedetto G, Pierangeli M, Scalise A, Bertani A. Paraffin oil injection in the body: an obsolete and destructive procedure. Ann Plast Surg 2002; 49: 391-396.